Barinthus Biotherapeutics BRNS
BRNS
$0.74 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Barinthus Biotherapeutics (BRNS) Price to Earnings (2022)

Updated

Barinthus Biotherapeutics' (BRNS) Price to Earnings came in at 16.58 for Q4 2022, up 58.6% from the prior quarter.

Analysis

Barinthus Biotherapeutics (BRNS) Price to Earnings (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Barinthus Biotherapeutics 30.23 Mn 30.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 16.58
Sep 30, 2022 10.45
API Access

Barinthus Biotherapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=BRNS&period=max&api_key=YOUR_API_KEY